Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment

about

Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment

Item

http://www.wikidata.org/entity/Q58699639

description

article

@en

im November 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Concept of histone deacetylase ...... l carcinogenesis and treatment

@en

Concept of histone deacetylase ...... l carcinogenesis and treatment

@nl

type

Item

label

Concept of histone deacetylase ...... l carcinogenesis and treatment

@en

Concept of histone deacetylase ...... l carcinogenesis and treatment

@nl

prefLabel

Concept of histone deacetylase ...... l carcinogenesis and treatment

@en

Concept of histone deacetylase ...... l carcinogenesis and treatment

@nl

P1476

Concept of histone deacetylase ...... l carcinogenesis and treatment

@en

P2093

Aikaterini Mastoraki

http://www.w3.org/2001/XMLSchema#string

Dimitrios Moris

http://www.w3.org/2001/XMLSchema#string

Dimitrios Schizas

http://www.w3.org/2001/XMLSchema#string

Eleftherios Spartalis

http://www.w3.org/2001/XMLSchema#string

George Bagias

http://www.w3.org/2001/XMLSchema#string

Georgia-Sofia Karachaliou

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 4.0 License

P2860

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis

Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries

Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications

The development and potential clinical utility of biomarkers for HDAC inhibitors

The epigenomics of cancer

Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress

Histone acetyltransferase complexes: one size doesn't fit all

Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivo

RNAi screening identifies HAT1 as a potential drug target in esophageal squamous cell carcinoma.

P304

4635-4642

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V24.I41.4635

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Diamantis I Tsilimigras

Leon Naar

P5008

ScienceSource

P577

2018-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30416311

http://www.w3.org/2001/XMLSchema#string

P921

squamous cell carcinoma

Anzim

P932

6224471

http://www.w3.org/2001/XMLSchema#string